Thrombopoietin mimetics

Thrombopoietin mimetics are drugs that considerably increase platelet production by stimulating the receptor for the hormone thrombopoietin; Romiplostim and Eltrombopag are examples.[1] Thrombopoietin mimetics are a type of thrombopoietic agents. There has been a development of a registry of pregnant patients that were treated with these drugs.[2]

References

  1. ^ "JPAC - Transfusion Guidelines".
  2. ^ Ronald Hoffman; Edward J. Benz, Jr.; Leslie E. Silberstein; Helen Heslop; Jeffrey Weitz; John Anastasi (2013). Hematology: Basic Principles and Practice. Elsevier Health Sciences. p. 2135.


  • v
  • t
  • e
Cytokine receptor modulators
Chemokine
  • See here instead.
CSF
Erythropoietin
  • Agonists: ARA-290
  • Asialo erythropoietin
  • Carbamylated erythropoietin
  • CNTO-530
  • Darbepoetin alfa
  • Epoetin alfa
  • Epoetin beta
  • Epoetin delta
  • Epoetin epsilon
  • Epoetin gamma
  • Epoetin kappa
  • Epoetin omega
  • Epoetin theta
  • Epoetin zeta
  • Erythropoietin (EPO)
  • Erythropoietin-Fc
  • Methoxy polyethylene glycol-epoetin beta (CERA/Mircera)
  • Peginesatide
  • Pegol sihematide (EPO-018B)
G-CSF (CSF3)
GM-CSF (CSF2)
M-CSF (CSF1)
  • Kinase inhibitors: Agerafenib
SCF (c-Kit)
  • See here instead.
Thrombopoietin
Interferon
IFNAR (α/β, I)
IFNGR (γ, II)
IFNLR (λ, III)
  • See IL-28R (IFNLR) here instead.
Interleukin
  • See here instead.
TGFβ
  • See here instead.
TNF
  • See here instead.
Others
JAK
(inhibitors)
JAK1
JAK2
JAK3
TYK2
Others